Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Mon, 23.06.2025       Bilfinger SE

Bilfinger SE: Share Buyback Disclosure according to Art. 5 para. 1(b), para 3 of Regulation (EU) No. 596/2014 in connection with Art. 2 para. 2 and 3 of Delegated Regulation (EU) 2016/1052 Share buyback – 22. Interim Reporting In the time period from June 16, 2025 until and including June 20, 2025, a number of 14,075 shares were bought back wit [ … ]
Mon, 23.06.2025       CENTROTEC SE

  23.06.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
Mon, 23.06.2025       Mutares SE & Co. KGaA

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Mutares inte [ … ]
Mon, 23.06.2025       VinFuture

EQS Newswire / 23/06/2025 / 13:00 CET/CEST HANOI, VIETNAM - Media OutReach Newswire - 23 June 2025 - With the invention of solar cells using Passivated Emitter and Rear Contact (PERC) technology, Prof. Martin Andrew Green from the University of New South Wales (Australia) and his team made a groundbreaking contribution to green energy producti [ … ]
Mon, 23.06.2025       Parmantier & Cie. GmbH

Frankfurt am Main, June 23, 2025 – CLINUVEL Pharmaceuticals Ltd. (ASX: CUV; WKN: AOJEGY) is setting key strategic signals for its next growth phase: Following a full recovery, CEO Dr. Philippe Wolgen has returned to lead the company’s operations and is now driving forward expansion into the North American market. The targeted approval of SCENESSE®  [ … ]
Mon, 23.06.2025       CLINUVEL Pharmaceuticals

Company Name: CLINUVEL Pharmaceuticals ISIN: AU000000CUV3   Reason for the research: Research Update Recommendation: Buy from: 23.06.2025 Target price: 22.00 AU$ Target price on sight of: 12 month Last rating change: none Analyst: Thomas Schiessle, Daniel Großjohann CEO Dr. Philippe Wolgen back on board – SCENESSE® [ … ]
Mon, 23.06.2025       Startup x Innovation Thailand Expo 2025 (SITE 2025)

EQS Newswire / 23/06/2025 / 12:00 CET/CEST BANGKOK, THAILAND - Media OutReach Newswire - 20 June 2025 - The National Innovation Agency (Public Organization) or NIA, under the Ministry of Higher Education, Science, Research and Innovation, has announced its readiness to host the Startup x Innovation Thailand Expo 2025 (SITE 2025) under the them [ … ]
Mon, 23.06.2025       Linde plc

Linde Signs Long-Term Agreement to Supply Industrial Gases to World-Scale Low-Carbon Ammonia Facility in Louisiana Woking, UK, June 23, 2025 – Linde (Nasdaq: LIN) today announced it has signed a new long-term agreement with Blue Point Number One, a joint venture between CF Industries, JERA and Mitsui & Co. Under the terms of the agreement, Li [ … ]
Mon, 23.06.2025       DHL

EQS Newswire / 23/06/2025 / 11:45 CET/CEST Offers comprehensive end-to-end solutions tailored for Indonesian businesses' unique needs and multinational enterprises seeking to expand locally Sees opportunities in the new energy, life sciences and healthcare, and e-commerce sectors Supports Indonesia's net-zero ambitions  [ … ]
Mon, 23.06.2025       PETRONAS Lubricants International

EQS Newswire / 23/06/2025 / 11:30 CET/CEST MUMBAI, INDIA - Media OutReach Newswire - 23 June 2025 - PETRONAS Lubricants (India) Pvt. Ltd. (PLIPL), a subsidiary of PETRONAS Lubricants International (PLI), has been awarded the Aftermarket Service Fill contract by Mahindra & Mahindra Ltd. (Mahindra), India's leading SUV manufacturer, strength [ … ]

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
About the newsfeed
#1
Where does the information come from?

The information is provided as part of a content partnership by one of Europe's leading news data providers, the Munich-based EQS Group.

#2
Will editorial changes be made?
The portal site is part of the EQS-Newswire distribution network. The information is provided 'as is'. No editorial adjustments are made. The detailed views are enriched with additional information in order to offer interested investors further research options.
#3
From which news source does the information originate?
As a rule, it is the companies themselves that provide information, either through their own public relations work or via partner agencies. Due to the wide reach of the EQS distribution network and the associated multiplier effects, this service is often used to reach interested parties quickly and in a targeted manner. The EQS Group counts almost all listed companies among its customers.
#4
Are the messages provided in real time?

The data feeds are updated at regular intervals. You can obtain the latest information directly from EQS if required. Simply follow the link below.

#5
Are there plans to expand the scope of the news?

If investor-relevant topics are involved, it is possible to connect additional data providers. In Q1/2024, mwb Research was added to the information offering in the rating area.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Monday, 23.06.2025, Calendar Week 26, 174th day of the year, 191 days remaining until EoY.